Latest news
Silexion Therapeutics publishes corporate deck spotlighting SIL204 siRNA program targeting KRAS-driven cancers - BitgetBitget · Sun, 09 Aug 2026 13:24:56 GMTCancer treatment makes tumor vulnerable to immune system attack, research finds - The Jerusalem PostThe Jerusalem Post · Wed, 05 Aug 2026 11:47:00 GMTSilexion Therapeutics Reports New Positive Preclinical - GlobeNewswireGlobeNewswire · Tue, 04 Aug 2026 13:15:00 GMTIsraeli scientists launch worlds-first clinical trial for experimental pancreatic cancer treatment - The Jerusalem PostThe Jerusalem Post · Thu, 30 Jul 2026 07:00:00 GMTSilexion Therapeutics Successfully Initiates Phase 2/3 - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 11:00:00 GMTSilexion Opens Its First Pancreatic Cancer Trial Site in Israel - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT